Get startedLog in
    Picture of Shanghai Junshi Biosciences logo

    1877 — Shanghai Junshi Biosciences News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapSucker Stock
    All News

    Brief: Shanghai Junshi Biosciences Says Js125 Received Notice Of Approval- For Clinical Trial

    Picture of Shanghai Junshi Biosciences logoShanghai Junshi Biosciences
    26/09/2024 17:27
    Sept 26 (Reuters) - Shanghai Junshi Biosciences
 688180.SS :
    * JS125 RECEIVED NOTICE OF APPROVAL- FOR CLINICAL TRIAL
    * INVESTIGATIONAL NEW DRUG APPLICATION FOR WJ47156 TABLETS
HAS
BEEN APPROVED BY NMPA

Further company coverage:  688180.SS 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Shanghai Junshi Biosciences

    See all news